In this study, PL was used as an effective adjuvant treatment in reinforcing the ZA-modulated antiosteoclastogenesis and antitumorigenesis both in vitro and in vivo by simulating ANP structure synergistically to target competitively phosphorylation of JNK/Erk, thereby decreasing breast cancer-induced osteoclast formation. This evidence concerns the gene NPPA and breast cancer.